نتایج جستجو برای: complete response

تعداد نتایج: 1300289  

Journal: :Cancer Therapy & Oncology International Journal 2020

Journal: :middle east journal of cancer 0
shapour omidvari department of radiation oncology, namazi hospital, shiraz university of medical sciences, shiraz, iran sare hosseini department of radiation oncology, namazi hospital, shiraz university of medical sciences, shiraz, iran yaghoub ashouri department of radiation oncology, namazi hospital, shiraz university of medical sciences, shiraz, iran sedigheh tahmasebi department of surgery, shahid faghihi hospital, shiraz university of medical sciences, shiraz, iran abdolrasoul talei department of surgery, shahid faghihi hospital, shiraz university of medical sciences, shiraz, iran hamid nasrolahi department of radiation oncology, namazi hospital, shiraz university of medical sciences, shiraz, iran

background : the present study aimed to compare the rates of complete clinical and pathologic response to docetaxel, doxorubicin and cyclophosphamide (tac) vs. 5-fluorouracil, doxorubicin and cyclophosphamide (fac) as neoadjuvant chemotherapy in women with locally advanced breast cancer. methods : one hundred women with pathologically confirmed newly diagnosed locally advanced (t3-t4 or n2-n3) ...

To study the resistance to standard dosage of clopidogrel among Iranian patients following percutaneous coronary intervention measured by platelet aggregation test.Patients undergoing percutaneous coronary intervention in Imam Hussein Medical center, Tehran, Iran, who were under treatment with aspirin, but had no history of clopidogrel usage, entered the study. Patients received standard dosage...

To study the resistance to standard dosage of clopidogrel among Iranian patients following percutaneous coronary intervention measured by platelet aggregation test.Patients undergoing percutaneous coronary intervention in Imam Hussein Medical center, Tehran, Iran, who were under treatment with aspirin, but had no history of clopidogrel usage, entered the study. Patients received standard dosage...

 فریدون معماری, ,  ماندانا زنگنه, , جهانگیر رأفت, , زهرا صدیقی, , صنمبر صدیقی, , علی منتظری, , علیرضا موسوی‌جراحی, , محمدعلی محققی, , مریم مستقیمی‌تهرانی, ,

Background: This prospective phase III study was designed to compare the activity of two combinations chemotherapy drugs in advanced gastric adenocarcinoma Methods: In a double blinded clinical trial, From Jan. 2002 to Jan. 2005, ninety patients with advanced gastric adenocarcinoma were randomly assigned to 1) Cisplatin and continuous infusion of 5FU and Epirubicin (ECF), and 2) Cisplatin and ...

2012
Jason B. Nikas Walter C. Low Paul A. Burgio

Pertaining to the female population in the USA, breast cancer is the leading cancer in terms of annual incidence rate and, in terms of mortality, the second most lethal cancer. There are currently no biomarkers available that can predict which breast cancer patients will respond to chemotherapy with both sensitivity and specificity > 80%, as mandated by the latest FDA requirements. In this stud...

F. Azmoodeh Ardalan, M. Aghili, M. Babaei, M. Ganjalikhani,

Background: In recent years, neoadjuvant chemoradiation and subsequent surgical resection with total mesorectal excision has been shown to increase local control with decreased toxicity. Neoadjuvant chemoradiotherapy is the standard treatment for locally advanced rectal cancer. In this study we evaluated the efficacy a cox-2 inhibitor on pathologic response, sphincter preservation and acute tox...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید